BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23060932)

  • 1. Potential clinical significance of plasma-based KRAS mutation analysis using the COLD-PCR/TaqMan(®) -MGB probe genotyping method.
    Liu P; Liang H; Xue L; Yang C; Liu Y; Zhou K; Jiang X
    Exp Ther Med; 2012 Jul; 4(1):109-112. PubMed ID: 23060932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-amplification at lower denaturation-temperature PCR combined with unlabled-probe high-resolution melting to detect KRAS codon 12 and 13 mutations in plasma-circulating DNA of pancreatic adenocarcinoma cases.
    Wu J; Zhou Y; Zhang CY; Song BB; Wang BL; Pan BS; Lou WH; Guo W
    Asian Pac J Cancer Prev; 2014; 15(24):10647-52. PubMed ID: 25605154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coamplification at lower denaturation temperature-PCR increases mutation-detection selectivity of TaqMan-based real-time PCR.
    Li J; Wang L; Jänne PA; Makrigiorgos GM
    Clin Chem; 2009 Apr; 55(4):748-56. PubMed ID: 19233916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
    Carotenuto P; Roma C; Cozzolino S; Fenizia F; Rachiglio AM; Tatangelo F; Iannaccone A; Baron L; Botti G; Normanno N
    Int J Oncol; 2012 Feb; 40(2):378-84. PubMed ID: 21971641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS gene mutation in a series of unselected colorectal carcinoma patients with prognostic morphological correlations: a pyrosequencing method improved by nested PCR.
    de Macêdo MP; de Melo FM; Lisboa BC; Andrade LD; de Souza Begnami MD; Junior SA; Ribeiro HS; Soares FA; Carraro DM; da Cunha IW
    Exp Mol Pathol; 2015 Jun; 98(3):563-7. PubMed ID: 25835782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer.
    Kuo YB; Chen JS; Fan CW; Li YS; Chan EC
    Clin Chim Acta; 2014 Jun; 433():284-9. PubMed ID: 24685572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population.
    Hao YX; Li YM; Ye M; Guo YY; Li QW; Peng XM; Wang Q; Zhang SF; Zhao HX; Zhang H; Li GH; Zhu JH; Xiao WH
    Oncol Lett; 2017 May; 13(5):3608-3616. PubMed ID: 28521461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients.
    Taly V; Pekin D; Benhaim L; Kotsopoulos SK; Le Corre D; Li X; Atochin I; Link DR; Griffiths AD; Pallier K; Blons H; Bouché O; Landi B; Hutchison JB; Laurent-Puig P
    Clin Chem; 2013 Dec; 59(12):1722-31. PubMed ID: 23938455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice.
    Sundström M; Edlund K; Lindell M; Glimelius B; Birgisson H; Micke P; Botling J
    BMC Cancer; 2010 Dec; 10():660. PubMed ID: 21122130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-associated clonal hematopoiesis mutations should be taken seriously in plasma cell-free DNA KRAS/NRAS/BRAF genotyping for metastatic colorectal cancer.
    Huang F; Yang Y; Chen X; Jiang H; Wang H; Shen M; Yu Y; Liu T; Pan B; Wang B; Guo W
    Clin Biochem; 2021 Jun; 92():46-53. PubMed ID: 33737000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid detection of epidermal growth factor receptor mutations in non-small cell lung cancer using real-time polymerase chain reaction with TaqMan-MGB probes.
    Zhou C; Ni J; Zhao Y; Su B
    Cancer J; 2006; 12(1):33-9. PubMed ID: 16613660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of KRAS mutation status in metastatic colorectal cancer patients.
    Zavodna K; Konecny M; Krivulcik T; Spanik S; Behulova R; Vizvaryova M; Weismanova E; Galbavy S; Kausitz J
    Neoplasma; 2009; 56(3):275-8. PubMed ID: 19309232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of real-time PCR-optimized oligonucleotide probe method and Sanger sequencing for detection of KRAS mutations in colorectal and lung carcinomas].
    Qiu T; Ling Y; Chen Z; Shan L; Guo L; Lü N; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):599-602. PubMed ID: 23157827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COLD-PCR enhanced melting curve analysis improves diagnostic accuracy for KRAS mutations in colorectal carcinoma.
    Pritchard CC; Akagi L; Reddy PL; Joseph L; Tait JF
    BMC Clin Pathol; 2010 Nov; 10():6. PubMed ID: 21110880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of KRAS Mutations in Plasma DNA Using a fully Automated Rapid Detection System in Colorectal Cancer Patients.
    Hosoya K; Matsusaka S; Kashiwada T; Suzuki K; Ureshino N; Sato A; Miki Y; Kitera K; Hirai M; Hatake K; Kimura S; Sueoka-Aragane N
    Pathol Oncol Res; 2017 Oct; 23(4):737-744. PubMed ID: 28058585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of epidermal growth factor receptor mutations in non-small cell lung cancer by real-time PCR using TaqMan-MGB probes].
    Zhou CC; Zhou SW; Pan H; Su B; Gao ZQ
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):119-23. PubMed ID: 17645848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased sensitivity of KRAS mutation detection by high-resolution melting analysis of COLD-PCR products.
    Kristensen LS; Daugaard IL; Christensen M; Hamilton-Dutoit S; Hager H; Hansen LL
    Hum Mutat; 2010 Dec; 31(12):1366-73. PubMed ID: 20848649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of genetic and epigenetic alterations of primary tumors and matched plasma samples in patients with colorectal cancer.
    Danese E; Minicozzi AM; Benati M; Montagnana M; Paviati E; Salvagno GL; Lima-Oliveira G; Gusella M; Pasini F; Lippi G; Guidi GC
    PLoS One; 2015; 10(5):e0126417. PubMed ID: 25946211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications.
    Pu X; Pan Z; Huang Y; Tian Y; Guo H; Wu L; He X; Chen X; Zhang S; Lin T
    Oncol Lett; 2013 Jan; 5(1):249-254. PubMed ID: 23255930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.